Reactivation of Latent Mycobacterium Tuberculosis Infection with Different Outcomes after in Vitro Fertilization and Embryo Transfer: Two Case Reports

Xiaohong Li,Jiahui Qiu,Yuanji Ma,Tao Cui
DOI: https://doi.org/10.21037/gpm-22-28
2023-01-01
Gynecology and Pelvic Medicine
Abstract:Background: Genital tuberculosis (TB) is a common form of extrapulmonary TB associated with female infertility and often exists without specific clinical manifestations. In vitro fertilization and embryo transfer (IVF-ET) has made it possible for women with latent TB to conceive. The pregnancy leads to an increased incidence of reactivation of latent TB. TB related maternal and neonatal complications has increased in recent years after IVF-ET. Chest X-ray is a routine screening procedure for active TB before IVF-ET. However, most women with latent TB do not exhibit pulmonary symptoms and usually negative results are reported. Therefore, screening for latent TB infection before IVF-ET is particularly important which holds benefits for both mother and child. In contrast, no consensus was reached regarding screening latent TB before IVF-ET. The current study presents two cases of latent TB infection before IVF-ET and discuss the different outcomes due to the screening of latent TB before IVF-ET. Case Description: Two women without a history of TB, aged 32 and 33 years, underwent IVF-ET due to infertility. Both women had granulomatous inflammation detected on endometrial biopsy. A diagnosis of TB was considered, but tests for acid-fast bacilli and TB DNA were negative. One woman received IVF-ET and conceived. She was diagnosed with pulmonary TB with hematogenous dissemination at 10 weeks gestation, miscarried during antituberculosis treatment and recovered after a antituberculosis therapy. The other woman tested positive for TB by an interferon-gamma release assay (IGRA). Embryo transfer was postponed until she had completed antituberculosis therapy. Conclusions: Women undergoing IVF-ET are at a high risk of reactivation of latent TB infection. Clinicians should screen patients for signs of TB before performing IVF-ET. Specific tests such as tuberculin skin test (TST) or IGRA can be used to identify latent TB before embryo transfer in patients with suspected TB.
What problem does this paper attempt to address?